Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Shares withheld for taxes Chairman and CEO gave up 25,710 shares (to pay taxes)
  2. 4 Shares withheld for taxes VP and Chief Compliance Office gave up 1,186 shares (to pay taxes)
  3. 4 Shares withheld for taxes Vice Pres Sales & Marketing gave up 593 shares (to pay taxes)
  4. 4 Shares withheld for taxes Vice Pres Organizational Dev gave up 816 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP Chief Financial Officer gave up 445 shares (to pay taxes)
  6. 4 Other acquisition Director acquired 1,174 shares (code L)
  7. 4 Other acquisition Director acquired 1,174 shares (code L)
  8. 4 Other acquisition Director acquired 6,407 shares (code L)
  9. 4 Other acquisition Chairman and CEO acquired 1,174 shares (code L)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 352 shares (to pay taxes)
  11. 4 Other acquisition Director acquired 952 shares (code L)
  12. 4 Other acquisition Director acquired 952 shares (code L)
  13. 4 Other acquisition Chairman and CEO acquired 952 shares (code L)
  14. 4/A Other acquisition Director acquired 2,011 shares (code L)
  15. 4 Other acquisition Director acquired 2,852 shares (code L)
  16. 4 Other acquisition Director acquired 1,148 shares (code L)
  17. 4 Other acquisition Director acquired 1,148 shares (code L)
  18. 4 Other acquisition Chairman and CEO acquired 1,148 shares (code L)
  19. 4 Other acquisition Director acquired 2,814 shares (code L)
  20. 4 Other acquisition Director acquired 3,027 shares (code L)

Page 6 of 26 · 512 filings